Chinese Journal of Tissue Engineering Research ›› 2012, Vol. 16 ›› Issue (35): 6636-6640.doi: 10.3969/j.issn.2095-4344.2012.35.033

Previous Articles     Next Articles

Survey on osteoporosis medical therapy in patients with osteoporotic hip fracture

Wang Hong1, Li Ming-sheng2, Chen Hai-ling1, Deng Li-li1, Zhang Quan3, Deng Wei1, Li Wei1   

  1. 1Department of Endocrinology, 3Department of Orthopedic trauma, Beijing Jishuitan Hospital, Beijing 100035, China;
    2Department of Center Out-patient, General Staff Headquarters Management & Security Department of Chinese PLA, Beijing 100087, China
  • Received:2012-04-25 Revised:2012-06-11 Online:2012-08-26 Published:2012-08-26
  • Contact: Chen Hai-ling, Doctor, Attending physician, Department of Endocrinology, Beijing Jishuitan Hospital, Beijing 100035, China hailing_chen@263.net
  • About author:Wang Hong, Associate chief physician, Department of Endocrinology, Beijing Jishuitan Hospital, Beijing 100035, China wanghong_43@sohu.com

PDF

552

Abstract:

BACKGROUND: Osteoporosis of the hip is the main reason for the osteoporotic fracture.
OBJECTIVE: To investigate whether osteoporosis was evaluated and treated appropriately in patients more than 50 years old with hip osteoporotic fracture．
METHODS: The patients suffered from hip osteoporotic fracture and treated in Beijing Jishuitan Hospital during July 2009 to December 2010 were enrolled. Information were collected from electronic medical records and telephone follow-up, and 484 patients were investigated, the survey including bone mineral density examination, application status of anti-osteoporosis drug and awareness rate of osteoporosis.
RESULTS AND CONCLUSION: Among 484 patients, bone mineral density examination was performed only in 13 patients (2.7%), 46 patients (9.5%) treated with anti-osteoporosis drugs before fracture, 93 patients (19.2%) received bone mineral density examination and 219 patients (45.2%) were treated with anti-osteoporosis drugs during hospitalization, 14 patients (2.9%) received bone mineral density examination and 96 patients (19.8%) were treated with anti-osteoporosis drugs during hospitalization during follow-up. The application rate of anti-osteoporosis drugs during follow-up was significantly higher than that before hospitalization (P = 0.000). The awareness rate for the patients and their families was 45.9%, and 54% of the patients obtained the information from medical staff. Most patients with hip osteoporotic fracture do not receive adequate anti-osteoporosis drugs or appropriate evaluation before fracture and during rehabilitation, so the awareness rate and the treatment rate of osteoporosis was low．

CLC Number: